New Diabetes Drug Shows Effectiveness

Tuesday, 16 Apr 2013 12:15 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
Eli Lilly and Co said two additional late-stage studies testing its experimental diabetes drug dulaglutide met the main goal of reducing hemoglobin A1c levels, a measure of blood sugar.
 
Along with positive results from three other late-stage trials announced in October, the data will support a marketing application for dulaglutide, Lilly said in a statement.
 
In the study named AWARD 2, the company said a 1.5 mg dose of its drug proved superior to Sanofi's Lantus, at 52 weeks in Type 2 diabetes patients, who are already on two other diabetes drugs, metformin and glimeperide.
 
Dulaglutide also trumped insulin lispro, in combination with Lantus, at 26 weeks of treatment in a study dubbed as AWARD 4, Lilly said.
 
The company said the most frequently reported adverse events were gastrointestinal.
 
In October, Lilly reported positive results of the other three studies in which dulaglutide was compared with other diabetes medications.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Sunscreen Chemicals Cut Men's Fertility: NIH

Monday, 24 Nov 2014 16:08 PM

A new study suggests that chemicals in sunscreen may impair men's ability to father children, government scientists say. . . .

Obese Kids Often Face Liver Disease

Monday, 24 Nov 2014 15:57 PM

Obese children are at increased for liver disease, high blood pressure and heart disease, a new study warns.
Resear . . .

Brain Training in Elderly Boosts Concentration: Study

Monday, 24 Nov 2014 13:59 PM

The aging brain is more susceptible to distractions, but new research says it's possible to diminish distractibility by  . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved